The DOI matches its Crossref record; 224 of the 224 references it cites were found in a registry or an index.
Opportunities and challenges for co-delivery nanomedicines based on combination of phytochemicals with chemotherapeutic drugs in cancer treatment
Abstract
The therapeutic limitations such as insufficient efficacy, drug resistance, metastasis, and undesirable side effects are frequently caused by the long duration monotherapy based on chemotherapeutic drugs. multiple combinational anticancer strategies such as nucleic acids combined with chemotherapeutic agents, chemotherapeutic combinations, chemotherapy and tumor immunotherapy combinations have been embraced, holding great promise to counter these limitations, while still taking including some potential risks. Nowadays, an increasing number of research has manifested the anticancer effects of phytochemicals mediated by modulating cancer cellular events directly as well as the tumor microenvironment. Specifically, these natural compounds exhibited suppression of cancer cell proliferation, apoptosis, migration and invasion of cancer cells, P-glycoprotein inhibition, decreasing vascularization and activation of tumor immunosuppression. Due to the low toxicity and multiple modulation pathways of these phytochemicals, the combination of chemotherapeutic agents with natural compounds acts as a novel approach to cancer therapy to increase the efficiency of cancer treatments as well as reduce the adverse consequences. In order to achieve the maximized combination advantages of small-molecule chemotherapeutic drugs and natural compounds, a variety of functional nano-scaled drug delivery systems, such as liposomes, host-guest supramolecules, supramolecules, dendrimers, micelles and inorganic systems have been developed for dual/multiple drug co-delivery. These co-delivery nanomedicines can improve pharmacokinetic behavior, tumor accumulation capacity, and achieve tumor site-targeting delivery. In that way, the improved antitumor effects through multiple-target therapy and reduced side effects by decreasing dose can be implemented. Here, we present the synergistic anticancer outcomes and the related mechanisms of the combination of phytochemicals with small-molecule anticancer drugs. We also focus on illustrating the design concept, and action mechanisms of nanosystems with co-delivery of drugs to synergistically improve anticancer efficacy. In addition, the challenges and prospects of how these insights can be translated into clinical benefits are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
4 retracted
Zhang, P., Lai, Z., Chen, H., Zhang, M., Wang, A., Jia, T., Sun, W., Zhu, X., Chen, X., Zhao, Z., et al. (2017) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-017-0661-7 · Cited by 107
Self-citationRetractedRETRACTED: Chlorogenic Acid Improves the Regorafenib Effects in Human Hepatocellular Carcinoma Cells
Refolo, M. G., Lippolis, C., Carella, N., Cavallini, A., Messa, C., & D’Alessandro, R. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19051518 · Cited by 61
RetractedAmoodizaj, F. F., Baghaeifar, S., Taheri, E., Jadid, M. F. S., Safi, M., Sani, N. S., Hajazimian, S., Isazadeh, A., & Shanehbandi, D. (2020) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.22486 · Cited by 52
RetractedXiaomeng, F., Lei, L., An, J., Jiang, J., Qi, Y., & Yuan, D. (2020) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20208885 · Cited by 26
RetractedSung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699
Mechanisms of Cancer Drug Resistance
Gottesman, M. M. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.103929 · Cited by 2,643
Combination therapy in combating cancer
Mokhtari, R. B., Homayouni, T. S., Baluch, N., Morgatskaya, E., Kumar, S., Das, B., & Yeger, H. (2017) · Oncotarget · doi:10.18632/oncotarget.16723 · Cited by 2,543
Jang, S. C., Kim, O. Y., Yoon, C. M., Choi, D.-S., Roh, T.-Y., Park, J., Nilsson, J., Lötvall, J., Kim, Y.-K., & Gho, Y. S. (2013) · ACS Nano · doi:10.1021/nn402232g · Cited by 1,022
Combination cancer immunotherapies tailored to the tumour microenvironment
Smyth, M. J., Ngiow, S. F., Ribas, A., & Teng, M. W. L. (2016) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.209 · Cited by 944
Resveratrol as an anti-cancer agent: A review
Rauf, A., Imran, M., Butt, M. S., Nadeem, M., Peters, D. G., & Mubarak, M. S. (2018) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2016.1263597 · Cited by 663
From traditional Chinese medicine to rational cancer therapy
Efferth, T., Li, P. C. H., Konkimalla, V. S. B., & Kaina, B. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.07.001 · Cited by 528
The Multifaceted Role of Curcumin in Cancer Prevention and Treatment
Shanmugam, M., Rane, G., Kanchi, M., Arfuso, F., Chinnathambi, A., Zayed, M., Alharbi, S., Tan, B., Kumar, A., & Sethi, G. (2015) · Molecules · doi:10.3390/molecules20022728 · Cited by 510
Chrysin: Sources, beneficial pharmacological activities, and molecular mechanism of action
Mani, R., & Natesan, V. (2018) · Phytochemistry · doi:10.1016/j.phytochem.2017.09.016 · Cited by 461
Combining Nanomedicine and Immunotherapy
Shi, Y., & Lammers, T. (2019) · Accounts of Chemical Research · doi:10.1021/acs.accounts.9b00148 · Cited by 457
Chen, P., Wu, Q., Feng, J., Yan, L., Sun, Y., Liu, S., Xiang, Y., Zhang, M., Pan, T., Chen, X., et al. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0149-3 · Cited by 413
Self-citationChung, J. E., Tan, S., Gao, S. J., Yongvongsoontorn, N., Kim, S. H., Lee, J. H., Choi, H. S., Yano, H., Zhuo, L., Kurisawa, M., et al. (2014) · Nature Nanotechnology · doi:10.1038/nnano.2014.208 · Cited by 412
Chen, P., Li, X., Zhang, R., Liu, S., Xiang, Y., Zhang, M., Chen, X., Pan, T., Yan, L., Feng, J., et al. (2020) · Theranostics · doi:10.7150/thno.44705 · Cited by 403
Self-citationBayet-Robert, M., Kwiatowski, F., Leheurteur, M., Gachon, F., Planchat, E., Abrial, C., Mouret-Reynier, M.-A., Durando, X., Barthomeuf, C., & Chollet, P. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.9.1.10392 · Cited by 399
Kanai, M., Yoshimura, K., Asada, M., Imaizumi, A., Suzuki, C., Matsumoto, S., Nishimura, T., Mori, Y., Masui, T., Kawaguchi, Y., et al. (2011) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-010-1470-2 · Cited by 399
Nanomedicine of synergistic drug combinations for cancer therapy – Strategies and perspectives
Zhang, R. X., Wong, H. L., Xue, H. Y., Eoh, J. Y., & Wu, X. Y. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.06.012 · Cited by 380
Pharmacological properties and derivatives of shikonin—A review in recent years
Guo, C., He, J., Song, X., Tan, L., Wang, M., Jiang, P., Li, Y., Cao, Z., & Peng, C. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104463 · Cited by 374
Colorectal Cancer Chemotherapy: The Evolution of Treatment and New Approaches
McQuade, R. M., Stojanovska, V., Bornstein, J. C., & Nurgali, K. (2017) · Current Medicinal Chemistry · doi:10.2174/0929867324666170111152436 · Cited by 350
The Four-Herb Chinese Medicine PHY906 Reduces Chemotherapy-Induced Gastrointestinal Toxicity
Lam, W., Bussom, S., Guan, F., Jiang, Z., Zhang, W., Gullen, E. A., Liu, S.-H., & Cheng, Y.-C. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001270 · Cited by 344
Baicalin induces ferroptosis in bladder cancer cells by downregulating FTH1
Kong, N., Chen, X., Feng, J., Duan, T., Liu, S., Sun, X., Chen, P., Pan, T., Yan, L., Jin, T., et al. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.03.036 · Cited by 297
Self-citationXu, J., Liu, D., Niu, H., Zhu, G., Xu, Y., Ye, D., Li, J., & Zhang, Q. (2017) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-016-0487-8 · Cited by 283
Bijnsdorp, I. V., Giovannetti, E., & Peters, G. J. (2011) · Methods in Molecular Biology · doi:10.1007/978-1-61779-080-5_34 · Cited by 252
Zhai, B., Zhang, N., Han, X., Li, Q., Zhang, M., Chen, X., Li, G., Zhang, R., Chen, P., Wang, W., et al. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108812 · Cited by 249
Self-citationMeng, J., Guo, F., Xu, H., Liang, W., Wang, C., & Yang, X.-D. (2016) · Scientific Reports · doi:10.1038/srep22390 · Cited by 236
Jain, A. K., Thanki, K., & Jain, S. (2013) · Molecular Pharmaceutics · doi:10.1021/mp400311j · Cited by 235
Natural products for treating colorectal cancer: A mechanistic review
Huang, X.-M., Yang, Z.-J., Xie, Q., Zhang, Z.-K., Zhang, H., & Ma, J.-Y. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109142 · Cited by 225
Gastro-intestinal toxicity of chemotherapeutics in colorectal cancer: The role of inflammation
Lee, C. S. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i14.3751 · Cited by 224
Therapeutic effects of EGCG: a patent review
Chakrawarti, L., Agrawal, R., Dang, S., Gupta, S., & Gabrani, R. (2016) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2016.1203419 · Cited by 221
Kallifatidis, G., Labsch, S., Rausch, V., Mattern, J., Gladkich, J., Moldenhauer, G., Büchler, M. W., Salnikov, A. V., & Herr, I. (2011) · Molecular Therapy · doi:10.1038/mt.2010.216 · Cited by 218
Woo, C. C., Hsu, A., Kumar, A. P., Sethi, G., & Tan, K. H. B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075356 · Cited by 216
Oxaliplatin-induced peripheral neuropathy: clinical features, mechanisms, prevention and treatment
Kang, L., Tian, Y., Xu, S., & Chen, H. (2021) · Journal of Neurology · doi:10.1007/s00415-020-09942-w · Cited by 212
Zhao, R., Li, T., Zheng, G., Jiang, K., Fan, L., & Shao, J. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.07.030 · Cited by 207
Panahi, Y., Saadat, A., Beiraghdar, F., & Sahebkar, A. (2014) · Phytotherapy Research · doi:10.1002/ptr.5149 · Cited by 204
Lu, X., Yang, F., Chen, D., Zhao, Q., Chen, D., Ping, H., & Xing, N. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.41686 · Cited by 203
Wan, X., Beaudoin, J. J., Vinod, N., Min, Y., Makita, N., Bludau, H., Jordan, R., Wang, A., Sokolsky, M., & Kabanov, A. V. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2018.10.032 · Cited by 201
Kunnumakkara, A. B., Diagaradjane, P., Anand, P., Kuzhuvelil, H. B., Deorukhkar, A., Gelovani, J., Guha, S., Krishnan, S., & Aggarwal, B. B. (2009) · International Journal of Cancer · doi:10.1002/ijc.24593 · Cited by 199
Kanai, M., Otsuka, Y., Otsuka, K., Sato, M., Nishimura, T., Mori, Y., Kawaguchi, M., Hatano, E., Kodama, Y., Matsumoto, S., et al. (2013) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-013-2151-8 · Cited by 198
Improving human cancer therapy through the evaluation of pet dogs
LeBlanc, A. K., & Mazcko, C. N. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-020-0297-3 · Cited by 198
Honokiol: A Review of Its Anticancer Potential and Mechanisms
Ong, C. P., Lee, W. L., Tang, Y. Q., & Yap, W. H. (2019) · Cancers · doi:10.3390/cancers12010048 · Cited by 196
Banik, K., Ranaware, A. M., Deshpande, V., Nalawade, S. P., Padmavathi, G., Bordoloi, D., Sailo, B. L., Shanmugam, M. K., Fan, L., Arfuso, F., et al. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.04.004 · Cited by 189
Kim, H., Kim, E. H., Eom, Y. W., Kim, W.-H., Kwon, T. K., Lee, S. J., & Choi, K. S. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1568 · Cited by 181
A Review on Preparation of Betulinic Acid and Its Biological Activities
Lou, H., Li, H., Zhang, S., Lu, H., & Chen, Q. (2021) · Molecules · doi:10.3390/molecules26185583 · Cited by 170
Ishitsuka, K., Hideshima, T., Hamasaki, M., Raje, N., Kumar, S., Hideshima, H., Shiraishi, N., Yasui, H., Roccaro, A. M., Richardson, P., et al. (2005) · Blood · doi:10.1182/blood-2005-01-0346 · Cited by 169
Magnolol: A Neolignan from the Magnolia Family for the Prevention and Treatment of Cancer
Ranaware, A., Banik, K., Deshpande, V., Padmavathi, G., Roy, N., Sethi, G., Fan, L., Kumar, A., & Kunnumakkara, A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082362 · Cited by 167
Burnett, J., Lim, G., Li, Y., Shah, R. B., Lim, R., Paholak, H. J., McDermott, S., Sun, L., Tsume, Y., Bai, S., et al. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.02.023 · Cited by 163
Bashmail, H. A., Alamoudi, A. A., Noorwali, A., Hegazy, G. A., AJabnoor, G., Choudhry, H., & Al-Abd, A. M. (2018) · Scientific Reports · doi:10.1038/s41598-018-30046-z · Cited by 163
Chen, P., Huang, H.-P., Wang, Y., Jin, J., Long, W.-G., Chen, K., Zhao, X.-H., Chen, C.-G., & Li, J. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1234-8 · Cited by 161
Pastorelli, D., Fabricio, A. S. C., Giovanis, P., D'Ippolito, S., Fiduccia, P., Soldà, C., Buda, A., Sperti, C., Bardini, R., Dalt, G. D., et al. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.03.013 · Cited by 160
Anitha, A., Deepa, N., Chennazhi, K. P., Lakshmanan, V.-K., & Jayakumar, R. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2014.06.004 · Cited by 158
Lan, C.-Y., Chen, S.-Y., Kuo, C.-W., Lu, C.-C., & Yen, G.-C. (2019) · Journal of Food and Drug Analysis · doi:10.1016/j.jfda.2019.07.001 · Cited by 158
Old formula, new Rx: The journey of PHY906 as cancer adjuvant therapy
Liu, S.-H., & Cheng, Y. (2012) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2012.01.047 · Cited by 151
The progress and perspective of strategies to improve tumor penetration of nanomedicines
Hu, J., Yuan, X., Wang, F., Gao, H., Liu, X., & Zhang, W. (2020) · Chinese Chemical Letters · doi:10.1016/j.cclet.2020.11.006 · Cited by 144
Xavier, C. P. R., Lima, C. F., Rohde, M., & Pereira‐Wilson, C. (2011) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-011-1641-9 · Cited by 142
Khan, S., Setua, S., Kumari, S., Dan, N., Massey, A. E., Hafeez, B. B., Yallapu, M. M., Stiles, Z. E., Alabkaa, A., Yue, J., et al. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.04.005 · Cited by 136
Yang, C., Song, J., Hwang, S., Choi, J., Song, G., & Lim, W. (2021) · Redox Biology · doi:10.1016/j.redox.2021.102144 · Cited by 135
Lei, X., Xiao-guang, L., Liu, M., Yang, Z., Ji, M., Guo, X., & Dong, W. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.12.063 · Cited by 132
Du, G., Lin, H., Wang, M., Zhang, S., Wu, X., Lu, L., Ji, L., & Yu, L. (2009) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-009-1032-7 · Cited by 130
Doxorubicin and resveratrol co-delivery nanoparticle to overcome doxorubicin resistance
Zhao, Y., Huan, M., Liu, M., Cheng, Y., Sun, Y., Cui, H., Liu, D., Mei, Q., & Zhou, S. (2016) · Scientific Reports · doi:10.1038/srep35267 · Cited by 130
Liu, M., Fu, M., Yang, X., Jia, G., Shi, X., Ji, J., Liu, X., & Zhai, G. (2020) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2020.111284 · Cited by 129
Wang, J., Liu, D., Guan, S., Zhu, W., Li, F., Zhang, Q., & Cai, D. (2020) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2020.115981 · Cited by 125
SYNTHESIS: Cancer research meets evolutionary biology
Pepper, J. W., Findlay, C. S., Kassen, R., Spencer, S. L., & Maley, C. C. (2009) · Evolutionary Applications · doi:10.1111/j.1752-4571.2008.00063.x · Cited by 118
Yuan, H., Che, S., Hui, B., Yang, Y.-Y., Wang, X., Zhang, X., Qiang, Y., & Ma, H. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108614 · Cited by 118
Insights on the Multifunctional Activities of Magnolol
Zhang, J., Chen, Z., Huang, X., Shi, W., Zhang, R., Chen, M., Huang, H., & Wu, L. (2019) · BioMed Research International · doi:10.1155/2019/1847130 · Cited by 117
Self-citationHsu, H.-Y., Lin, T.-Y., Hu, C.-H., Shu, D. T. F., & Lu, M.-K. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.05.006 · Cited by 116
Lam, W., Jiang, Z., Guan, F., Huang, X., Hu, R., Wang, J., Bussom, S., Liu, S.-H., Zhao, H., Yen, Y., et al. (2015) · Scientific Reports · doi:10.1038/srep09384 · Cited by 116
Narayanan, S., Mony, U., Vijaykumar, D. K., Koyakutty, M., Paul‐Prasanth, B., & Menon, D. (2015) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2015.03.015 · Cited by 112
Yongvongsoontorn, N., Chung, J. E., Gao, S. J., Bae, K. H., Yamashita, A., Tan, M., Ying, J. Y., & Kurisawa, M. (2019) · ACS Nano · doi:10.1021/acsnano.9b00467 · Cited by 111
Li, C., Chu, C.-Y., Huang, L.-H., Wang, M., Sheu, L., Yeh, J., & Hsu, H. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.01.006 · Cited by 110
Wang, L., Li, Y., Sn, Y., Wang, F.-Y., Hou, Y., Cui, W., Chen, K., Cao, Q., Wang, S., Ty, Z., et al. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.752 · Cited by 110
Fang, J., Zhang, S., Xue, X., Zhu, X., Song, S., Wang, B., Jiang, L., Qin, M., Liang, H., & Gao, L. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s170862 · Cited by 110
Zhang, L., Wang, G., Hou, W., et al. (2009) · Hepatology · doi:10.1002/hep.23384 · Cited by 109
Narayanan, S., Pavithran, M., Viswanath, A., et al. (2014) · Acta Biomaterialia · doi:10.1016/j.actbio.2013.12.041 · Cited by 108
Raza, K., Kumar, D., Thakur, C. K., Kumar, M., Guru, S. K., Kumar, P., Arora, S., Sharma, G., Bhushan, S., & Katare, O. P. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00183 · Cited by 107
Park, B. H., Lim, J. E., Jeon, H. G., Seo, S. I., Lee, H. M., Choi, H. Y., Jeon, S. S., & Jeong, B. C. (2016) · Oncotarget · doi:10.18632/oncotarget.11563 · Cited by 106
Anti-proliferative and chemosensitizing effects of luteolin on human gastric cancer AGS cell line
Wu, B., Zhang, Q., Shen, W., & Zhu, J. (2008) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-008-9749-x · Cited by 105
Saneja, A., Kumar, R., Mintoo, M. J., Dubey, R. D., Sangwan, P. L., Mondhe, D. M., Panda, A. K., & Gupta, P. N. (2019) · Materials Science and Engineering C · doi:10.1016/j.msec.2019.01.026 · Cited by 104
Reversal of Resistance towards Cisplatin by Curcumin in Cervical Cancer Cells
Roy, M., & Mukherjee, S. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.3.1403 · Cited by 103
Vakilinezhad, M. A., Amini, A., Dara, T., & Alipour, S. (2019) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2019.110515 · Cited by 103
Han, W., Shi, L., Ren, L., Zhou, L., Li, T., Qiao, Y., & Wang, H. (2018) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-018-0019-4 · Cited by 102
Zhao, M., Li, J.-Q., Chen, F., Dong, W., Wen, L., Fei, W., Zhang, X., Yang, P.-L., Zhang, X., & Zheng, C. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s224579 · Cited by 102
Takasuna, K., Kasai, Y., Kitano, Y., Mori, K., Kobayashi, R., Hagiwara, T., Kakihata, K., Hirohashi, M., Nomura, M., Nagai, E., et al. (1995) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1995.tb03010.x · Cited by 100
Zhang, Y., Li, Q., Wang, J., Cheng, F., Huang, X., Cheng, Y., & Wang, K. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.04.037 · Cited by 100
Celastrol inhibits rheumatoid arthritis through the ROS-NF-κB-NLRP3 inflammasome axis
Jing, M. X., Yang, J., Zhang, L., Liu, J., Xu, S., Wang, M., Zhang, L., Sun, Y. M., Yan, W.-B., Hou, G., et al. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107879 · Cited by 100
Howells, L. M., Sale, S., Sriramareddy, S. N., Irving, G. R. B., Jones, D. J. L., Ottley, C. J., Pearson, D. G., Mann, C. D., Manson, M. M., Berry, D. P., et al. (2010) · International Journal of Cancer · doi:10.1002/ijc.25670 · Cited by 97
Singh, R. (2017) · Frontiers in Bioscience-Elite · doi:10.2741/e798 · Cited by 97
El-Readi, M. Z., Eid, S. Y., Abdelghany, A. A., Al-Amodi, H. S. A. B., Efferth, T., & Wink, M. (2018) · Phytomedicine · doi:10.1016/j.phymed.2018.06.046 · Cited by 96
Gu, Z., Wang, Q., Shi, Y., Huang, Y., Zhang, J., Zhang, X., & Lin, G. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.08.011 · Cited by 96
Self-citationZhang, J., Zhang, H.-D., Yao, Y., Zhong, S., Zhao, J. H., & Tang, J. H. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000430191 · Cited by 94
Self-citationTsai, L., Hsieh, H., Lu, K.-Y., Wang, S.-Y., & Mi, F. (2015) · Nanomedicine · doi:10.2217/nnm.15.183 · Cited by 94
Yang, H., Huang, S., Wei, Y., Cao, S., Pi, C., Feng, T., Liang, J., Zhao, L., & Ren, G. (2017) · Journal of Cancer · doi:10.7150/jca.20196 · Cited by 94
Bose, C., Awasthi, S., Sharma, R., Beneš, H., Hauer‐Jensen, M., Boerma, M., & Singh, S. P. (2018) · PLoS ONE · doi:10.1371/journal.pone.0193918 · Cited by 92
Hu, J. X., Wang, J., Wang, G., Yao, Z., & Dang, X. (2016) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2016.2458 · Cited by 90
Zhang, M., Hagan, C. T., Min, Y., Foley, H., Tian, X., Yang, F., Mi, Y., Au, K. M., Medik, Y. B., Roche, K. C., et al. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.03.055 · Cited by 88
Zhang, Y., Wang, X., Han, L., Zhou, Y., & Sun, S. (2014) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2014.12.016 · Cited by 87
Dong, J., Su, S., Wang, M., & Zhan, Z. (2010) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-29-137 · Cited by 87
Therapeutic Targeting of CPT-11 Induced Diarrhea: A Case for Prophylaxis
Swami, U., Goel, S., & Mani, S. (2013) · Current Drug Targets · doi:10.2174/1389450111314070007 · Cited by 86
Ma, L., Li, W., Wang, R., Nan, Y., Wang, Q., Liu, W., & Jin, F. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.3124 · Cited by 85
Self-citationLiu, S., Li, R., Jin, Q. Y., Sun, J., Li, G., Shen, J., & Xie, Y. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c00138 · Cited by 85
Curcumin formulated in solid lipid nanoparticles has enhanced efficacy in Hodgkin's lymphoma in mice
Guorgui, J. G., Wang, R., Mattheolabakis, G., & Mackenzie, G. G. (2018) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2018.04.012 · Cited by 83
Yin, J., Wang, L., Wang, Y., Shen, H., Wang, X., & Wu, L. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s199601 · Cited by 83
Lin, J., Cai, Q., Tang, Y., Xu, Y., Wang, Q., Li, T., Xu, H., Wang, S., Fan, K., Liu, Z., et al. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.10.043 · Cited by 82
Şakalar, Ç., İzgi, K., İskender, B., Sezen, S., Aksu, H., Çakır, M., Kurt, B., Turan, A., & Canatan, H. (2015) · Tumor Biology · doi:10.1007/s13277-015-4307-0 · Cited by 81
Yuan, Y., Li, J., Han, J., Hou, N., Song, Y., & Dong, L. (2015) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000218 · Cited by 80
Lev‐Ari, S., Zinger, H., Kazanov, D., Yona, D., Ben‐Yosef, R., Starr, A., Figer, A., & Arber, N. (2005) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(05)80045-9 · Cited by 80
Lin, J., Chen, S., Lu, C., Lin, J., & Yen, G. (2020) · Phytotherapy Research · doi:10.1002/ptr.6669 · Cited by 80
Borska, S., Sopel, M., Chmielewska, M., Zabel, M., & Dzięgiel, P. (2010) · Molecules · doi:10.3390/molecules15020857 · Cited by 77
Zhang, Z., Xu, S., Wang, Y., Yu, Y., Li, F., Zhu, H., Shen, Y., Huang, S., & Guo, S. (2017) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2017.08.097 · Cited by 77
Shi, J., Ren, Y., Ma, J., Luo, X., Li, J., Wu, Y., Gu, H., Fu, C., Cao, Z., & Zhang, J. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-00934-0 · Cited by 77
Self-citationJakubíková, J., Cervi, D. N., Ooi, M. G. M., Kım, K., Nahar, S., Klippel, S., Cholujová, D., Leiba, M., Daley, J. F., Delmore, J. E., et al. (2011) · Haematologica · doi:10.3324/haematol.2010.029363 · Cited by 76
Combination of chrysin and cisplatin promotes the apoptosis of Hep G2 cells by up-regulating p53
Li, X., Huang, J., Wang, J., Xiong, X.-K., Yang, X., & Zou, F. (2015) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2015.03.003 · Cited by 76
Prevention and Treatment of Colorectal Cancer by Natural Agents from Mother Nature
Aggarwal, B. B., Prasad, S., Sung, B., Krishnan, S., & Guha, S. (2013) · Current Colorectal Cancer Reports · doi:10.1007/s11888-012-0154-1 · Cited by 75
Thakkar, A. D., Chenreddy, S., Wang, J., & Prabhu, S. V. (2015) · Cell & Bioscience · doi:10.1186/s13578-015-0041-y · Cited by 74
Wang, E., Bussom, S., Chen, J., Quinn, C., Bedognetti, D., Lam, W., Guan, F., Jiang, Z., Mark, Y., Zhao, Y., et al. (2011) · BMC Medical Genomics · doi:10.1186/1755-8794-4-38 · Cited by 74
Sensitizing the Therapeutic Efficacy of Taxol with Shikonin in Human Breast Cancer Cells
Li, W., Liu, J., Jackson, K. L., Shi, R., & Zhao, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094079 · Cited by 73
Rasheduzzaman, M., Jeong, J., & Park, S. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.07.035 · Cited by 73
Luo, Y., Li, J., Hu, Y., Gao, F., Pak-Heng Leung, G., Geng, F., Fu, C., & Zhang, J. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.05.011 · Cited by 72
Self-citationWang, Y., Ma, J., Qiu, T., Tang, M., Zhang, X., & Dong, W. (2021) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2021.105864 · Cited by 71
Lu, Y., Runzhe, Z., Zhang, X., Zhang, B., & Yao, Q. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110381 · Cited by 71
Milczarek, M., Wiktorska, K., Mielczarek, L., Koronkiewicz, M., Dąbrowska, A., Lubelska, K., Matosiuk, D., & Chilmończyk, Z. (2017) · Food and Chemical Toxicology · doi:10.1016/j.fct.2017.10.056 · Cited by 70
Tang, J., Ren, Y., Zhao, J., Long, F., Chen, J.-Y., & Jiang, Z. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.05.012 · Cited by 70
Zou, L., Liu, X., Li, J., Li, W., Zhang, L., Fu, C., Zhang, J., & Gu, Z. (2021) · Theranostics · doi:10.7150/thno.42260 · Cited by 70
Self-citationBandey, I. N., Chiou, S.-H., Huang, A.-P., Tsai, J.-C., & Tu, P.-H. (2014) · Oncogene · doi:10.1038/onc.2014.92 · Cited by 69
Mao, J., Yang, H., Cui, T., Pan, P., Kabir, N., Chen, D., Ma, J., Chen, X., Chen, Y., & Yang, Y. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.05.027 · Cited by 69
Zhou, Y., Zhang, J., Wang, K., Han, W., Wang, X., Gao, M., Wang, Z., Sun, Y., Yan, H., Zhang, H., et al. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173185 · Cited by 69
Self-citationDai, N., Ye, R., He, Q., Guo, P., Chen, H., & Zhang, Q. (2018) · Oncology Reports · doi:10.3892/or.2018.6754 · Cited by 67
Zhang, Y., Huang, L., Shi, H., Chen, H., Tao, J., Shen, R., & Wang, T. (2017) · Cancer Science · doi:10.1111/cas.13425 · Cited by 65
Kumar, M. R. P., Sharma, G., Misra, C., Kumar, R., Singh, B., Katare, O. P., & Raza, K. (2018) · Materials Science and Engineering C · doi:10.1016/j.msec.2018.03.033 · Cited by 65
Barros, A. S., Costa, E. C., Nunes, A. S., de Melo‐Diogo, D., & Correia, I. J. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.09.016 · Cited by 65
Xu, H., Luo, R., Dong, L., Pu, X., Chen, Q., Ye, N., Qi, S., Han, X., Nie, W., Fu, C., et al. (2021) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2021.102461 · Cited by 65
Self-citationZhu, H., Yang, W., He, L., Ding, W., Zheng, L., Liao, S., Huang, P. C., Lu, W. P., He, Q., & Yang, B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052333 · Cited by 64
Hou, G., Yuan, X., Li, Y., Hou, G., & Liu, X. (2019) · Investigational New Drugs · doi:10.1007/s10637-019-00781-9 · Cited by 64
Ability to Acquire Drug Resistance Arises Early during the Tumorigenesis Process
Yagüe, E., Arance, A. M., Kubitza, L., O’Hare, M. J., Jat, P., Ogilvie, C. M., Hart, I. R., Higgins, C. F., & Raguz, S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2574 · Cited by 63
Yan, T., Li, D., Li, J., Cheng, F., Cheng, J., Huang, Y., & He, J. (2016) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2016.05.070 · Cited by 63
Ursolic acid synergistically enhances the therapeutic effects of oxaliplatin in colorectal cancer
Shan, J., Xuan, Y., Zhang, Q., Zhu, C., Liu, Z., & Zhang, S. (2016) · Protein & Cell · doi:10.1007/s13238-016-0295-0 · Cited by 63
Wang, R., Huang, J., Chen, J., Yang, M., Wang, H., Qiao, H., Chen, Z., Hu, L., Di, L., & Li, J. (2019) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2019.102068 · Cited by 63
Kaminski, B. M., Weigert, A., Brüne, B., Schumacher, M., Wenzel, U., Steinhilber, D., Stein, J. M., & Ulrich, S. (2010) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-010-1413-y · Cited by 62
Li, K., Liu, W., Zhao, Q., Wu, C., Fan, C., Lai, H., & Li, S. (2019) · Phytotherapy Research · doi:10.1002/ptr.6353 · Cited by 61
Self-citationResveratrol as an Enhancer of Apoptosis in Cancer: A Mechanistic Review
Ashrafizadeh, M., Taeb, S., Haghi‐Aminjan, H., Afrashi, S., Moloudi, K., Musa, A. E., Najafi, M., & Farhood, B. (2020) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520620666201020160348 · Cited by 61
Zhou, L., Qi, L., Jiang, L., Zhou, P., Ma, J., Xu, X., & Li, P. (2014) · The AAPS Journal · doi:10.1208/s12248-013-9558-3 · Cited by 60
Dey, D. K., Chang, S. N., Vadlamudi, Y., Park, J. G., & Kang, S. C. (2020) · Food and Chemical Toxicology · doi:10.1016/j.fct.2020.111529 · Cited by 60
Zheng, Z., He-yi, Y., Feng, Y., & Zhang, Z. (2020) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-020-03856-x · Cited by 60
Huh, H.-C., Lee, S., Lee, S.-K., Park, N. H., & Han, I. (2011) · Nutrition and Cancer · doi:10.1080/01635581.2011.607548 · Cited by 59
Kang, X.-H., Xu, Z.-Y., Gong, Y.-B., Wang, L., Wang, Z., Xu, L., Cao, F., & Liao, M.-J. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/243859 · Cited by 59
Li, S., Liu, Z., Zhu, F., Fan, X., Wu, X., Zhao, H., & Jiang, L. (2014) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504013x13832473330032 · Cited by 59
Gao, J., Fan, K., Jin, Y., Zhao, L., Wang, Q., Tang, Y., Xu, H., Liu, Z., Wang, S., Lin, J., et al. (2019) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2019.105070 · Cited by 59
Bian, Y., & Guo, D. Y. (2020) · Drug Design Development and Therapy · doi:10.2147/dddt.s238955 · Cited by 59
Zhang, R., Pan, T. S., Yu, X., Zhang, M., Feng, J., Liu, S., Duan, T., Chen, P., Zhai, B., Chen, X., et al. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00378 · Cited by 59
Self-citationCui, D.-N., Wang, X., Chen, J., Lv, B., Zhang, P., Zhang, W., Zhang, Z., & Xu, F. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00211 · Cited by 58
Chen, C., Xiao, W., Huang, L., Yu, G., Ni, J., Yang, L., Wan, R., & Hu, G. (2017) · PubMed · Cited by 57
Shi, J., Li, J., Li, J., Li, R., Wu, X., Gao, F., Zou, L., Mak, W. W.-S., Fu, C., Zhang, J., et al. (2020) · Phytomedicine · doi:10.1016/j.phymed.2020.153408 · Cited by 57
Self-citationWei, R., Wirkus, J., Yang, Z., Machuca, J., Esparza, Y., & Mackenzie, G. G. (2020) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2020.108546 · Cited by 56
Zhou, Y., Tang, J., Du, Y., Ding, J., & Liu, J.-Y. (2016) · Tumor Biology · doi:10.1007/s13277-015-4719-x · Cited by 55
Xu, M., Li, G., Zhang, H., Chen, X., Li, Y., Yao, Q., & Xie, M. (2020) · Drug Delivery · doi:10.1080/10717544.2020.1785581 · Cited by 54
Gambogic acid potentiates gemcitabine induced anticancer activity in non-small cell lung cancer
Hatami, E., Nagesh, P. K. B., Jaggi, M., Chauhan, S. C., & Yallapu, M. M. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173486 · Cited by 54
He, P., Ma, J., Liu, Y., Deng, H., & Dong, W. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01326 · Cited by 54
Herbal Medicines for Irinotecan-Induced Diarrhea
Tang, L., Li, X., Wan, L., Xiao, Y., Zeng, X., & Ding, H. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00182 · Cited by 53
Zong, L., Cheng, G., Liu, S., Pi, Z., Liu, Z., & Song, F. (2018) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2018.11.057 · Cited by 52
Andjelković, T., Pešić, M., Banković, J., Tanić, N., Marković, I., & Ruždijić, S. (2008) · Cancer Biology & Therapy · doi:10.4161/cbt.7.7.6036 · Cited by 51
Banerjee, K., Banerjee, S., & Mandal, M. (2016) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2016.12.025 · Cited by 51
Chen, D., Zhang, F., Wang, J., He, H., Duan, S., Zhu, R., Chen, C., Yin, L., & Chen, Y. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01214 · Cited by 51
Xu, B., Guo, X., Mathew, S., Armesilla, A. L., Cassidy, J., Darling, J. L., & Wang, W. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.10.013 · Cited by 49
Chang, Z., Gao, M., Zhang, W., Song, L., Jia, Y., & Qin, Y. (2017) · Surgical Oncology · doi:10.1016/j.suronc.2017.07.002 · Cited by 49
Strouch, M. J., Milam, B. M., Melstrom, L. G., McGill, J. J., Salabat, M. R., Ujiki, M. B., Ding, X.-Z., & Bentrem, D. J. (2009) · Pancreas · doi:10.1097/mpa.0b013e318193a074 · Cited by 47
Yao, J. J., An, Y., Wie, J., Chen, P., Miao, Y., Ji, Z., Lu, Z. P., Jl, W., Jiang, K., & Xu, Z. (2011) · Swiss Medical Weekly · doi:10.4414/smw.2011.13208 · Cited by 46
NPCDR: natural product-based drug combination and its disease-specific molecular regulation
Sun, X., Zhang, Y., Zhou, Y., Lian, X., Yan, L., Pan, T. S., Jin, T., Xie, H., Liang, Z., Qiu, W., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab913 · Cited by 46
Self-citationQuercetin abrogates chemoresistance in melanoma cells by modulating ΔNp73
Thangasamy, T., Sittadjody, S., Mitchell, G. C., Mendoza, E. E., Radhakrishnan, V. M., Limesand, K. H., & Burd, R. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-282 · Cited by 45
BAHMAN, A.-M., Abaza, M. S. I., Khoushiash, S., & Al‐Attiyah, R. (2018) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2018.3725 · Cited by 45
(2022) · doi:10.1016/j.ajps.2021.12.003 · Cited by 44
Self-citationCurcumin Reduces Cytotoxicity of 5-Fluorouracil Treatment in Human Breast Cancer Cells
Ferguson, J. E., & Orlando, R. A. (2014) · Journal of Medicinal Food · doi:10.1089/jmf.2013.0086 · Cited by 44
Guo, L., Shen, Y., Zhao, X., Guo, L.-J., Yu, Z., Wang, D., Liu, L., & Liu, J. (2014) · Phytotherapy Research · doi:10.1002/ptr.5257 · Cited by 44
Triptolide Cooperates With Cisplatin to Induce Apoptosis in Gemcitabine-Resistant Pancreatic Cancer
Zhu, W., Li, J., Wu, S., Li, S., Le, L., Su, X., Qiu, P., Hu, H., & Yan, G. (2012) · Pancreas · doi:10.1097/mpa.0b013e31824abdc0 · Cited by 43
Gu, W., Liu, L., Fang, F., Huang, F., CHENG, B.-B., & Bai, L. (2013) · Oncology Reports · doi:10.3892/or.2013.2817 · Cited by 42
Shikonin reduces tamoxifen resistance through long non-coding RNA uc.57
Zhang, C.-H., Wang, J., Zhang, L.-X., Lu, Y.-H., Ji, T.-H., Xu, L., & Ling, L.-J. (2017) · Oncotarget · doi:10.18632/oncotarget.20809 · Cited by 42
Cao, F., Gong, Y., Kang, X., Lu, Z., Wang, Y., Zhao, K., Miao, Z., Liao, M., & Xu, Z. (2019) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2019.114662 · Cited by 42
Luteolin and Gemcitabine Protect Against Pancreatic Cancer in an Orthotopic Mouse Model
Johnson, J. L., Día, V. P., Wallig, M. A., & de Mejía, E. G. (2014) · Pancreas · doi:10.1097/mpa.0000000000000215 · Cited by 41
Lv, X., Qiao, X., Su, L., & Chen, S. (2016) · Acta Pharmacologica Sinica · doi:10.1038/aps.2016.81 · Cited by 41
Zang, H., Qian, G., Arbiser, J. L., Owonikoko, T. K., Ramalingam, S. S., Fan, S., & Sun, S. (2020) · Molecular Oncology · doi:10.1002/1878-0261.12645 · Cited by 41
Synergistic effect of 5-fluorouracil with gambogic acid on BGC-823 human gastric carcinoma
Wang, J., Liu, W., Zhao, Q., Qi, Q., Lu, N., Yang, Y., Nei, F.-F., Rong, J., You, Q., & Guo, Q. (2008) · Toxicology · doi:10.1016/j.tox.2008.11.014 · Cited by 39
Self-citationClinical cancer research: the past, present and the future
DeVita, V. T., Eggermont, A. M. M., Hellmän, S., & Kerr, D. J. (2014) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2014.153 · Cited by 38
Wong, F. Y., Liem, N. L. M., Xie, C., Yan, F. L., Wong, W. C., Wang, L., & Yong, W. P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050786 · Cited by 38
Lv, X., Liu, F., Shang, Y., & Chen, S. (2015) · Oncology Reports · doi:10.3892/or.2015.4091 · Cited by 37
Li, X., Ren, J., Wang, Y., Su, J., Zhu, Y., Chen, C.-G., Long, W., Jiang, Q., & Li, J. (2020) · Cellular Oncology · doi:10.1007/s13402-020-00557-x · Cited by 37
Vargas, J. E., Puga, R., Lenz, G., Trindade, C., & Filippi‐Chiela, E. C. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/5432651 · Cited by 37
Owumi, S. E., Nwozo, S. O., Arunsi, U. O., Oyelere, A. K., & Odunola, O. A. (2020) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2020.115380 · Cited by 37
Gautam, M., Thapa, R. K., Gupta, B., Soe, Z. C., Ou, W., Poudel, K., Jin, S. G., Choi, H., Yong, C. S., & Kim, J. O. (2020) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2020.1727442 · Cited by 36
Zhang, B., Zhang, X., Tang, B., Zheng, P., & Zhang, Y. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2263-6 · Cited by 35
Artesunate promotes sensitivity to sorafenib in hepatocellular carcinoma
Wu, J., Liu, S., Xing, Y., Mu, M., Zhao, R., Xie, J., & Hu, D. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.08.115 · Cited by 35
Yi, X., Lou, L., Wang, J., Xiong, J., & Zhou, S. (2021) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-021-04238-w · Cited by 35
Gao, Y., Li, H.-X., Xu, L.-T., Wang, P., Xu, L., Cohen, L. G., Yang, P.-Y., Gu, K., & Meng, Z.-Q. (2011) · Molecular Biology Reports · doi:10.1007/s11033-011-0908-x · Cited by 34
Si, W., Lyu, J., Liu, Z., Wang, C., Huang, J., Jiang, L., & Ma, T. (2019) · Journal of Cancer · doi:10.7150/jca.31303 · Cited by 34
Zhou, Y., Zhou, C., Zou, Y., Jin, Y., Han, S., Liu, Q., Hu, X., Wang, L., Ma, Y., & Liu, Y. (2020) · Biomaterials Science · doi:10.1039/d0bm00840k · Cited by 34
Chio, C., Tai, Y., Mohanraj, M., Liu, S., Yang, S., & Chen, R. (2018) · Phytomedicine · doi:10.1016/j.phymed.2018.06.012 · Cited by 33
Gan, D., He, W., Yin, H., & Gou, X. (2019) · Oncology Letters · doi:10.3892/ol.2019.11103 · Cited by 32
Yuan, H., Che, S., Hui, B., Wang, X., Zhang, X., & Ma, H. (2020) · Drug Design Development and Therapy · doi:10.2147/dddt.s241291 · Cited by 31
Honokiol augments the anti-cancer effects of oxaliplatin in colon cancer cells
Hua, H., Chen, W., Shen, L., Sheng, Q., & Teng, L. (2013) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmt071 · Cited by 30
Bufalin and 5‑fluorouracil synergistically induce apoptosis in colorectal cancer cells
Dai, X., Zhou, B., Xie, Y., Lou, J., & Li, K. (2018) · Oncology Letters · doi:10.3892/ol.2018.8332 · Cited by 30
Cited by
Natural Products as Anticancer Agents: Current Status and Future Perspectives
Naeem, A., Hu, P., Yang, M., Zhang, J., Liu, Y., Zhu, W., & Zheng, Q. (2022) · Molecules · doi:10.3390/molecules27238367 · Cited by 607
Self-citationLiu, Y., Liu, Y., Sun, X., Wang, Y., Du, C., & Bai, J. (2024) · Materials Today Bio · doi:10.1016/j.mtbio.2023.100903 · Cited by 19
Metadata
- Authors
- Gao, Q., Feng, J., Liu, W., Wen, C., Wu, Y., Liao, Q., Zou, L., Sui, X., Xie, T., Zhang, J., & Hu, Y.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2022-09
- Volume
- 188
- Pages
- 114445
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W4284961560
- Cited by
- 267
- References
- 224
- FWCI
- 3.24
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.